Records 1-5 (of 5 Records) |
Query Trace: BRD4[original query] |
---|
PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron. Acharya Arpan, et al. Clinical and translational medicine 2022 0 0. (4) e806 |
FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling. Zhou Dawei, et al. bioRxiv : the preprint server for biology 2021 0 0. |
In Silico investigation of the viroporin E as a vaccine target against SARS-CoV-2. Rouka Erasmia, et al. American journal of physiology. Lung cellular and molecular physiology 2021 0 0. |
Flavonoids against the SARS-CoV-2 induced inflammatory storm. Liskova Alena, et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 2 0. 111430 |
Quantum Deep Learning Functional Similarities on Remdesivir, Drug Synergies to Treat COVID-19 in Practice. Grigoriadis, Ioannis et al. Research Square December 17 2020 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 23, 2024
- Content source: